Gut Microbiota-derived Metabolites Regulate Intestinal Motility in Constipation: Mechanisms and Therapeutic Implications
- 15 November 2025
- journal article
- Published by Wonford Press Limited in Journal of Disease and Public Health
- Vol. 2 (2) , 1-6
Abstract
Constipation is a common gastrointestinal disorder characterized by infrequent bowel movements, difficult stool passage, excessive straining, and impaired colonic transit. Increasing evidence indicates that gut microbiota-derived metabolites are active regulators of intestinal motility rather than passive byproducts of luminal fermentation. In constipation, dysbiosis is often accompanied by reduced saccharolytic fermentation, altered bile acid biotransformation, disturbed tryptophan metabolism, and enhanced methanogenesis, all of which may contribute to delayed transit and stool desiccation. Short-chain fatty acids, secondary bile acids, tryptophan-derived metabolites, and methane influence motility through effects on enterochromaffin cells, serotonin biosynthesis, epithelial secretion, enteric neural circuits, mucosal immunity, and smooth muscle activity. These mechanistic insights have therapeutic implications. Dietary modulation, probiotics, synbiotics, fecal microbiota transplantation, and bile acid-targeted therapies may improve constipation partly by restoring a more favorable metabolite milieu. However, the causal role of individual metabolites in human constipation remains incompletely defined, and clinical responses are heterogeneous. This review summarizes current evidence on how gut microbiota-derived metabolites regulate intestinal motility in constipation and discusses the translational potential of metabolite-informed therapeutic strategies.Keywords
This publication has 20 references indexed in Scilit:
- British Dietetic Association Guidelines for the Dietary Management of Chronic Constipation in AdultsNeurogastroenterology & Motility, 2025
- Elobixibat Improves Stool/Gas Distribution and Fecal Bile Acids in Older Adults With Chronic ConstipationJGH Open, 2025
- American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic ConstipationGastroenterology, 2023
- Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studiesGut Microbes, 2022
- Epithelial 5-HT4 Receptors as a Target for Treating Constipation and Intestinal Inflammation2022
- Meta-analysis of randomized controlled trials of the effects of probiotics on functional constipation in adultsClinical Nutrition, 2020
- Bile acid receptors and gastrointestinal functionsLiver Research, 2019
- Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic SecretionCell Host & Microbe, 2018
- Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cellsThe FASEB Journal, 2014
- The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit timeNeurogastroenterology & Motility, 2011